SABCS 2022 Stromal Tumor-Infiltrating Lymphocytes Identify Early-Stage TNBC Patients With Favorable Outcomes at 10-Year Follow-Up in the Absence of Systemic Therapy: A Pooled Analysis of 1835 Patients

Tumor-Infiltrating Lymphocyte Therapy Approved by FDA | Immunology

An Overview on Tumor-Infiltrating Lymphocyte Therapy for Solid Tumors

The Cell Atlas

TIL Cell Therapy for Melanoma

Lifileucel TIL Cell Monotherapy in Patients With Advanced Melanoma After Progression on Immune Checkpoint Inhibitors and Targeted Therapy: Pooled Analysis of Consecutive Cohorts (C-144-01 Study)

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Isolation of tumor cells and tumor-infiltrating leukocytes for optimized downstream analysis